Akt Plays an Important Role in Lipopolysaccharide‐Induced Myocardial Injury and Protection

Yingmei Zhang,Wei Ge,Jun Ren
DOI: https://doi.org/10.1096/fasebj.24.1_supplement.1036.14
2010-01-01
Abstract:Lipopolysaccharide (LPS), an essential component of the outer membrane of Gram‐negative bacteria, plays a pivotal role in the pathogenesis of cardiac dysfunction in endotoxemia. Paradoxically, recent evidence also denoted a protective effect of LPS against ischemia/reperfusion injury via a PI3K/Akt pathway. This study was designed to evaluate the role of Akt in LPS‐induced cardiac dysfunction using a novel model of Akt knockout mice. Echocardiographic and cardiomyocyte function [peak shortening (PS), time‐to‐PS, time‐to‐90% relengthening (TR90)] were examined in C57 (wide‐type) and Akt2−/−mice treated with LPS (4 mg/kg, 4 hrs). Our results revealed that LPS treatment caused increased Akt phosphorylation in wide‐type mice while no change in Akt2−/−mice. Our results also revealed that either Akt2 knockout or LPS reduced fractional shortening (FS), PS and maximal velocity of shortening/relengthening as well as prolonged TR90. Interestingly, the mechanical dysfunctions seen in Akt2−/−mice were significantly improved by LPS. These data collectively suggested that Akt may be a double‐edged sword for endotoxemia‐induced cardiac contractile response.
What problem does this paper attempt to address?